A new trading day began on Monday, with Biohaven Ltd (NYSE: BHVN) stock price down -3.16% from the previous day of trading, before settling in for the closing price of $15.8. BHVN’s price has ranged from $12.79 to $54.98 over the past 52 weeks.
Annual sales at Healthcare sector company slipped by -49.78% over the past five years. Meanwhile, its annual earnings per share averaged 17.68%. With a float of $92.38 million, this company’s outstanding shares have now reached $105.78 million.
Biohaven Ltd (BHVN) Insider and Institutional Ownership
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Biohaven Ltd is 12.68%, while institutional ownership is 82.80%. The most recent insider transaction that took place on Mar 04 ’25, was worth 996,238. In this transaction Director of this company bought 32,700 shares at a rate of $30.47, taking the stock ownership to the 2,320,571 shares. Before that another transaction happened on Dec 30 ’24, when Company’s Director bought 29,000 for $35.94, making the entire transaction worth $1,042,393. This insider now owns 2,368,741 shares in total.
Biohaven Ltd (BHVN) Latest Financial update
In its latest quarterly report, released on 9/30/2024, the company reported earnings of -1.74 per share, which was $0.1 lower than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -1.47 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 17.68% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 21.99% during the next five years compared to -49.78% drop over the previous five years of trading.
Biohaven Ltd (NYSE: BHVN) Trading Performance Indicators
Here are Biohaven Ltd’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 3.82.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -7.66, a number that is poised to hit -1.88 in the next quarter and is forecasted to reach -5.98 in one year’s time.
